Drugs / Tomligisiran
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06537414 | Nov 2024 → May 2027 expected | chronic hepatitis B virus infection | GlaxoSmithKline | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tomligisiran | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06537414 ↗ |